- Home
- DCTH vs NCA Comparison
DCTH vs NCA Comparison
Compare DCTH & NCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCTH
- NCA
- Stock Information
- Founded
- DCTH 1988
- NCA 1987
- Country
- DCTH United States
- NCA United States
- Employees
- DCTH N/A
- NCA N/A
- Industry
- DCTH Medical/Dental Instruments
- NCA Investment Managers
- Sector
- DCTH Health Care
- NCA Finance
- Exchange
- DCTH Nasdaq
- NCA Nasdaq
- Market Cap
- DCTH 630.4M
- NCA 279.1M
- IPO Year
- DCTH N/A
- NCA N/A
- Fundamental
- Price
- DCTH $13.57
- NCA $8.58
- Analyst Decision
- DCTH Strong Buy
- NCA
- Analyst Count
- DCTH 4
- NCA 0
- Target Price
- DCTH $24.00
- NCA N/A
- AVG Volume (30 Days)
- DCTH 734.6K
- NCA 59.6K
- Earning Date
- DCTH 08-04-2025
- NCA 01-01-0001
- Dividend Yield
- DCTH N/A
- NCA 3.92%
- EPS Growth
- DCTH N/A
- NCA N/A
- EPS
- DCTH N/A
- NCA N/A
- Revenue
- DCTH $53,850,000.00
- NCA N/A
- Revenue This Year
- DCTH $155.42
- NCA N/A
- Revenue Next Year
- DCTH $37.93
- NCA N/A
- P/E Ratio
- DCTH N/A
- NCA N/A
- Revenue Growth
- DCTH 1068.87
- NCA N/A
- 52 Week Low
- DCTH $7.17
- NCA $7.77
- 52 Week High
- DCTH $18.23
- NCA $9.12
- Technical
- Relative Strength Index (RSI)
- DCTH 38.26
- NCA 52.12
- Support Level
- DCTH $12.98
- NCA $8.41
- Resistance Level
- DCTH $14.18
- NCA $8.48
- Average True Range (ATR)
- DCTH 0.68
- NCA 0.08
- MACD
- DCTH -0.28
- NCA 0.00
- Stochastic Oscillator
- DCTH 15.95
- NCA 45.00
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
About NCA Nuveen California Municipal Value Fund
Nuveen California Municipal Value Fund Inc is a diversified closed-end management investment company. Its primary objective is to provide current income exempt from regular federal and California income taxes. The fund's secondary objective is to enhance portfolio value relative to the California municipal bond market by investing in tax-exempt California municipal securities that the Fund's investment adviser and/or the Fund's sub-adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.